Maxpro Capital Acquisition said that its sponsor, MP One Investment, will deposit $1,035,000 (10 cents a share) into the company’s trust account by Oct. 13 for the first of two allowable deadline extensions.
The SPAC said it requires additional time to complete its merger with Apollomics, a deal with a pre-money equity value of $899 million. Announced last month, terms call for the biopharmaceutical company to receive up to $105 million of cash from the SPAC’s trust. The minimum cash condition is $20 million. Read more.
